Evidence map›Paper›PMID 35929632›Full record

ArticleCurrent HIV research2022

Effectors of Hyperlipidemia Among Patients with HIV/AIDS Taking Second-line Antiretroviral Therapy Based on Registry Data.

Chunling Yang, Dongli Wang, Yanmin Ma, Zhibin Liu, Huijun Guo, Feng Sang, Qianlei Xu, Yantao Jin

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Current HIV research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Chunling YangThe First Clinical Medical School, Henan University of Chinese Medicine, Zhengzhou, China.
Dongli WangThe First Clinical Medical School, Henan University of Chinese Medicine, Zhengzhou, China.
Yanmin MaCenter for AIDS/STD Control and Prevention, Center for Disease Control and Prevention of Henan Province, Zhengzhou, China.
Zhibin LiuThe First Clinical Medical School, Henan University of Chinese Medicine, Zhengzhou, China.
Huijun GuoDepartment of Acquired Immune Deficiency Syndrome Treatment and Research Center, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, China.
Feng SangHenan Key Laboratory of Viral Diseases Prevention and Treatment of Traditional Chinese Medicine, Henan University of Chinese Medicine, Zhengzhou, China.
Qianlei XuThe First Clinical Medical School, Henan University of Chinese Medicine, Zhengzhou, China.
Yantao JinDepartment of Acquired Immune Deficiency Syndrome Treatment and Research Center, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, China.
First Affiliated Hospital of Henan University · CNHenan Provincial Center for Disease Control and Prevention · CN

Funding

Henan Province TCM Research Project 2016ZY2036, 20-21ZYZD03Key Science and Technology Projects in Henan Province 202102310503National Natural Science Foundation of China 81803953, 81873289, 81873187
6 · The paper itself

Abstract

objectiveIn this study, we aimed to determine the prevalence and effectors of hyperlipidemia among People Living with HIV/AIDS (PLWHA) and taking second-line Antiretroviral Therapy (ART) using registry data in central China.

methodsWe conducted a cross-sectional study and collected information of PLWHA on secondline ART during 2018 from two medical registries. Hyperlipidemia was defined according to the 2016 Chinese guidelines for the management of dyslipidemia in adults. Univariate and multivariate logistic regression analyses were performed to explore the influencing factors of hyperlipidemia. We calculated Odds Ratios (ORs) and 95% Confidence Intervals (CIs).

resultsA total of 2886 PLWHA taking second-line ART were included in this study, and 978 (33.9%) had hyperlipidemia. Female patients, those with hyperglycemia, and patients with CD

conclusionPLWHA on second-line ART had a higher prevalence of hyperlipidemia. Gender, CD

Indexed as

Anti-HIV AgentsAnti-Retroviral AgentsHIV InfectionsHyperlipidemiasAdultAgedCD4 Lymphocyte CountChinaCross-Sectional StudiesFemaleHumansMaleMiddle AgedPrevalenceRegistriesRisk FactorsAnti-HIV AgentsAnti-Retroviral AgentsAIDScross-sectional studyHIVhyperlipidemiamortality.second-line ART

Identifiers

PMID35929632
PMCPMC9933044
OpenAlexW4289878636

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.